Breanna L. Sheldon

Breanna L. Sheldon

Auto-generated profile, based on publicly available information

Breanna L. Sheldon

Department of Neurosurgery, University of Arizona, Tucson, Arizona, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in World Neurosurgery
Verified
Journal Article
Closed access
DZDavid A. Zarrin
David A. Zarrin
BWBayard R. Wilson
Bayard R. Wilson
ZTZoe E. Teton
Zoe E. Teton
BSBreanna L. Sheldon
Breanna L. Sheldon
MDMichael J. Dorsi
Michael J. Dorsi

18 March 2025 in World Neurosurgery
Verified
Journal Article
Open access
BSBreanna L. Sheldon
Breanna L. Sheldon
CSCaitlin Scott
Caitlin Scott
LGLisa Goudman
Lisa Goudman
MDMarisa DiMarzio
Marisa DiMarzio
RHR. John Hurlbert
R. John Hurlbert

18 August 2021 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
BSBreanna L. Sheldon
Breanna L. Sheldon
MOMichael W. O’brien
Michael W. O’brien
MAMatthew A. Adamo
Matthew A. Adamo
Objectives Small pituitary cysts are commonly discovered on pediatric brain magnetic resonance imagings (MRIs), particularly in patients with growth hormone deficiency (GHD). We examined the need for operative management in children with these masses as well as the effect of growth hormone replacement (GHR) on these lesions. Methods This was a retrospective review of pituitary protocol MRIs conducted in children 0–19 at a single center between April 2010–November 2020. Sex, indication for initial MRI, volume, and whether surgery was performed was determined. Records were reviewed to determine whether GHD was present and treatment with GHR documented. For patients with subsequent MRIs, volume on most recent scan was calculated. Results Of the 101 children with cysts, 25 had laboratory-confirmed GHD and 76 did not. GHD patients had a higher mean age compared to no growth hormone deficiency (NGHD) cohort (11.2 and 8.4 years, respectively; p=0.02) and a larger proportion of males (p<0.001). The mean cyst volume on initial MRI was not significantly smaller in patients with GHD (0.063 ± 0.012 cm 3 ) vs. those without GHD (0.171 ± 0.039 cm 3 , p=0.11). Of the 21 GHD patients who received GHR and had follow-up MRIs, 10 had no change in pituitary cyst size, two had cysts that shrank, and seven disappeared. The remaining two cysts enlarged an average of 0.061 ± 0.033 cm 3 . Zero GHR recipients required surgical intervention. Conclusions Small sellar cysts discovered incidentally on imaging in children are unlikely to require surgical intervention. GHR does not appear to significantly enlarge these pediatric pituitary lesions and is safe for use.

16 June 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
BSBreanna L. Sheldon
Breanna L. Sheldon
JBJerry Mack Brown
Jerry Mack Brown
HOHasan Ozgur
Hasan Ozgur
RCRichard V. Chua
Richard V. Chua
BACKGROUND: Intracranial hypotension due to a CSF leak has many possible etiologies including traumatic dural tears, CSF-venous fistulas, iatrogenic causes, and elevated intracranial pressure. An example of traumatic rupture of a preexisting congenital spinal cyst (SC) in the sacrum causing a symptomatic CSF leak has not been described in the literature; therefore, the authors present the case of a 13-year-old female with a previously undiagnosed SC (Nabor type IB, sacral meningocele) found to have symptomatic intracranial hypotension following a ground-level fall. OBSERVATIONS: Traumatic rupture of SCs may cause a dural tear, resulting in stigmata of intracranial hypotension. LESSONS: SCs are rare entities that are often asymptomatic but should be carefully considered in the differential diagnoses for intracranial hypotension, even following low-impact trauma. Symptoms resolve with definitive treatment of dural tear, and recurrence rates are low. https://thejns.org/doi/10.3171/CASE2555

5 June 2023 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
JPJulie G. Pilitsis
Julie G. Pilitsis
TTThomas Tangney
Thomas Tangney
EHEhsaun Heydari
Ehsaun Heydari
BSBreanna Sheldon
Breanna Sheldon
ASAmit Shetty
Amit Shetty
OKOlga Khazen
Olga Khazen

21 August 2026 in Operative Neurosurgery
Verified
Journal Article
Closed access
BBBarbara Buccilli
Barbara Buccilli
BSBreanna Sheldon
Breanna Sheldon
SRSameena Rahman
Sameena Rahman
CCCarlos A. Cruz
Carlos A. Cruz
UKUgur Kilic
Ugur Kilic
JPJulie G. Pilitsis
Julie G. Pilitsis
BACKGROUND AND OBJECTIVE: Intrathecal drug delivery (IDD) is an established therapy for cancer-related pain, spasticity, and refractory noncancer-related chronic pain. Despite its clinical benefits, IDD implantation remains associated with a substantial complication burden, frequently necessitating revision surgery. Although complication rates are well described, operative strategies to mitigate these risks are inconsistently reported. We aimed to systematically map operative and perioperative strategies for IDD system implantation with a focus on complication mitigation, and to integrate practical technical insights into a standardized workflow with these data and our technical pearls garnered over 15 years. METHODS: A scoping review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines. PubMed/MEDLINE, Scopus, and Web of Science were searched from database inception through February 2026 for studies describing IDD implantation techniques, perioperative management, and associated complications. Eligible studies included randomized trials, observational studies, case series, and technical reports. Findings were synthesized qualitatively and organized according to the procedural workflow, including preoperative, intraoperative, and postoperative phases. RESULTS: A total of 45 studies met inclusion criteria. The most frequently reported complications included catheter-related malfunction, cerebrospinal fluid leaks, infection, and pump-related issues such as migration or rotation. Operative techniques to mitigate these risks are provided for catheter insertion approach, anchoring, and pump pocket construction. Infection prevention measures and standardized perioperative protocols also demonstrated an important role in reducing adverse events. We provide a workflow based on these data and our own experience. CONCLUSION: Complication risk in IDD implantation is strongly influenced by operative technique and perioperative management. Existing literature lacks standardization in both technical reporting and outcome definitions, highlighting the need for consensus frameworks. We provide a systems-based approach integrating procedural standardization, technical precision, and coordinated perioperative care may improve reproducibility and reduce complication rates.